Nephrol Dial Transplant (2002) 17: 1189-1196
© 2002 European Renal Association-European Dialysis and Transplant Association
Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis
1 Department of Pediatrics and 2 Department of Pharmacology, School of Medicine, University of Tokushima, Tokushima, Japan
Background. Matrix metalloproteinases (MMPs) have been implicated in the development of glomerular injury in rat experimental glomerulonephritis (GN). However, the significance of MMPs in human GN remains obscure. In order to evaluate the role of MMPs in human GN, we examined the glomerular distribution and gelatinolytic activities of MMP-2 and MMP-9 in human GN.
Methods. We performed immunohistochemistry with polyclonal anti-MMP-2 and MMP-9 antibodies, and analysed gelatin zymograms of five isolated glomeruli from various types of human renal disease. The renal specimens investigated were from normal kidneys (n=5), IgA nephritis (n=20), Henoch–Schönlein nephritis (n=4), non-IgA mesangial proliferative GN (n=9), lupus nephritis (n=6), acute poststreptococcal GN (APSGN) (n=4) and diabetic nephropathy (DN) (n=4).
Results. MMP-2 immunoreactivity was not detected in normal controls or in any type of GN. MMP-9 staining, which was almost negative in normal glomeruli, was increased mainly in the mesangial region and corresponded to the level of glomerular cell proliferative changes in mesangial proliferative GN (IgA nephritis, Henoch–Schönlein nephritis, non-IgA mesangial proliferative GN and lupus nephritis). Positive but weak staining for MMP-9 was observed in mesangial areas in DN. In addition, double immunostaining showed that MMP-9 is colocalized in scattered neutrophils within diseased glomeruli in APSGN. MMP-9 gelatinolytic activity in five normal glomeruli was weakly detected. Consistent with the levels of immunostaining, MMP-9 glomerular activity was dramatically increased in nephritic glomeruli with IgA nephritis, lupus nephritis and DN. The gelatinolytic activity of MMP-2 was occasionally detectable in nephritic glomeruli.
Conclusion. These results strongly suggest that MMP-9 plays an important role in abnormal mesangial proliferative changes in human GN.
Keywords: gelatin zymograms; human glomerulonephritis; immunohistochemistry; matrix metalloproteinases
Correspondence and offprint requests to: Shoji Kagami, Department of Pediatrics, School of Medicine, University of Tokushima, Kuramoto-cho 3-chome, Tokushima 770-8503, Japan. Email: kagami{at}clin.med.tokushima\|[hyphen]\|u.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Y. Yoon, S. C. Lee, Y. J. Park, and S.-H. Rha Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3236 - 3239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wornle, M. Roeder, M. Sauter, and A. Ribeiro Role of matrix metalloproteinases in viral-associated glomerulonephritis Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1113 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cosgrove, D. T. Meehan, D. Delimont, A. Pozzi, X. Chen, K. D. Rodgers, R. M. Tempero, M. Zallocchi, and V. H. Rao Integrin {alpha}1{beta}1 Regulates Matrix Metalloproteinases via P38 Mitogen-Activated Protein Kinase in Mesangial Cells: Implications for Alport Syndrome Am. J. Pathol., March 1, 2008; 172(3): 761 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Moussa, J. Apostolopoulos, P. Davenport, J. Tchongue, and P. G. Tipping Protease-Activated Receptor-2 Augments Experimental Crescentic Glomerulonephritis Am. J. Pathol., September 1, 2007; 171(3): 800 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bauvois, N. Mothu, J. Nguyen, T. Nguyen-Khoa, L.-H. Noel, and P. Jungers Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-{beta}1 in patients with distinct types of primary glomerulonephritis Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Rao, D. T. Meehan, D. Delimont, M. Nakajima, T. Wada, M. A. Gratton, and D. Cosgrove Role for Macrophage Metalloelastase in Glomerular Basement Membrane Damage Associated with Alport Syndrome Am. J. Pathol., July 1, 2006; 169(1): 32 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ronco and H. Debiec Molecular Pathomechanisms of Membranous Nephropathy: From Heymann Nephritis to Alloimmunization J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. F. Sanders, H. van Goor, R. Hanemaaijer, C. G. M. Kallenberg, and C. A. Stegeman Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1412 - 1419. [Abstract] [Full Text] [PDF]
|
|